Back to search
FDAFDA · Food and drugs·Recall number D-0032-2021

Losartan Pot/HCTZ 50/12.5 mg 90 Tabs Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Torrent Pharma, Inc. Basking Ridge, NJ 07920 NDC 61919-040-90

Published October 7, 2020 · Recall initiated: March 12, 2019

Summary

FDA records drug Class II recall D-0032-2021, published October 7, 2020 and initiated March 12, 2019. Recalling firm: Direct Rx; Status: Terminated; Reported quantity: 33 bottles; Lot: Lot: 12DE1806 Exp. 01/31/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP deviation: Trace amounts of impurity detected to be N-Methylnitrosobutyric acid (NMBA) in the API.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Direct Rx
Distributor
FL
Lot
Lot: 12DE1806 Exp. 01/31/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Losartan Pot/HCTZ 50/12.5 mg 90 Tabs Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg For: Torrent Pharma, Inc. Basking Ridge, NJ 07920 NDC 61919-040-90 recalled?

Yes. FDA published recall D-0032-2021 on October 7, 2020. Reported hazard: CGMP deviation: Trace amounts of impurity detected to be N-Methylnitrosobutyric acid (NMBA) in the API.

What should I do if I have this product?

Voluntary: Firm initiated · Letter